Originele taal-2 | English |
---|---|
Aantal pagina's | 2 |
Tijdschrift | Expert Review of Clinical Pharmacology |
Volume | 14 |
Nummer van het tijdschrift | 2 |
DOI's |
|
Status | Published - 21-jan.-2021 |
Response to Letter to the Editor re: "Serious adverse events and deaths in PCSK9 inhibitor trials reported on ClinicalTrials.gov: a systematic review": 'serious adverse events and deaths in PCSK9 inhibitor trials reported on ClinicalTrials.gov: a systematic review'
F H van Bruggen, G B J Nijhuis, S U Zuidema, H J Luijendijk*
*Corresponding author voor dit werk
Onderzoeksoutput › Academic › peer review
1
Citaat
(Scopus)
70
Downloads
(Pure)